Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherrie L Perkins

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Revised International Pediatric Non-Hodgkin Lymphoma Staging SystemAngelo Rosolen, Sherrie L Perkins, C Ross Pinkerton, et al.
British Journal of Haematology|July 30, 2013
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology GroupAmanda M Termuhlen, Lynette M Smith, Sherrie L Perkins, et al.
Pediatric Blood & Cancer|April 11, 2012
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology GroupAmanda M Termuhlen, Lynette M Smith, Sherrie L Perkins, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2003
Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primersVani Sabesan, Mitchell S Cairo, Mark A Lones, et al.
The American Journal of Surgical Pathology|April 17, 2004
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphomaChung-Che Chang, Sara McClintock, Ronald P Cleveland, et al.
British Journal of Haematology|August 1, 2012
TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of casesVasiliki Leventaki, Vladimir Rodic, Sheryl R Tripp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2014
Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasmNikhil A Sangle, Robert L Schmidt, Jay L Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
International Pediatric Non-Hodgkin Lymphoma Response CriteriaJohn T Sandlund, R Paul Guillerman, Sherrie L Perkins, et al.
Pediatric Blood & Cancer|April 24, 2019
IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trialsKaren M Chisholm, Jeffrey Mohlman, Michael Liew, et al.
American Journal of Clinical Pathology|March 15, 2005
Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantationLouis Novoa-Takara, Sherrie L Perkins, Dan Qi, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Revised International Pediatric Non-Hodgkin Lymphoma Staging SystemAngelo Rosolen, Sherrie L Perkins, C Ross Pinkerton, et al.
British Journal of Haematology|July 30, 2013
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology GroupAmanda M Termuhlen, Lynette M Smith, Sherrie L Perkins, et al.
Pediatric Blood & Cancer|April 11, 2012
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology GroupAmanda M Termuhlen, Lynette M Smith, Sherrie L Perkins, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2003
Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primersVani Sabesan, Mitchell S Cairo, Mark A Lones, et al.
The American Journal of Surgical Pathology|April 17, 2004
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphomaChung-Che Chang, Sara McClintock, Ronald P Cleveland, et al.
British Journal of Haematology|August 1, 2012
TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of casesVasiliki Leventaki, Vladimir Rodic, Sheryl R Tripp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2014
Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasmNikhil A Sangle, Robert L Schmidt, Jay L Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
International Pediatric Non-Hodgkin Lymphoma Response CriteriaJohn T Sandlund, R Paul Guillerman, Sherrie L Perkins, et al.
Pediatric Blood & Cancer|April 24, 2019
IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trialsKaren M Chisholm, Jeffrey Mohlman, Michael Liew, et al.
American Journal of Clinical Pathology|March 15, 2005
Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantationLouis Novoa-Takara, Sherrie L Perkins, Dan Qi, et al.
Pageof 13